FOXK2 and metabolic disease: Addressing these challenges will advance our understanding of FOXK2’s role in tumor formation, proliferation, invasion and metastasis, as well as in cancer therapy or drug resistance, eventually paving the way for targeting FOXK2 in the treatment of cancer and metabolic diseases.